C Pertusa

1.6k total citations
14 papers, 1.1k citations indexed

About

C Pertusa is a scholar working on Surgery, Oncology and Urology. According to data from OpenAlex, C Pertusa has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 5 papers in Oncology and 3 papers in Urology. Recurrent topics in C Pertusa's work include Bladder and Urothelial Cancer Treatments (10 papers), Urinary and Genital Oncology Studies (8 papers) and Colorectal Cancer Screening and Detection (4 papers). C Pertusa is often cited by papers focused on Bladder and Urothelial Cancer Treatments (10 papers), Urinary and Genital Oncology Studies (8 papers) and Colorectal Cancer Screening and Detection (4 papers). C Pertusa collaborates with scholars based in Spain. C Pertusa's co-authors include Santiago Isorna, Rosário Madero, José Emilio Camacho, Ander Astobieta, Eduardo Solsona, J A Martínez-Piñeiro, Luis Martínez‐Piñeiro, Mariano Rabadán, Miguel Unda and J.M. Fernández Gómez and has published in prestigious journals such as The Journal of Urology, European Urology and British Journal of Urology.

In The Last Decade

C Pertusa

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Pertusa Spain 8 1.0k 360 201 138 123 14 1.1k
José Emilio Camacho Spain 6 1.2k 1.1× 404 1.1× 204 1.0× 154 1.1× 111 0.9× 6 1.2k
Mariano Rabadán Spain 8 977 0.9× 333 0.9× 188 0.9× 130 0.9× 141 1.1× 8 1.0k
Miguel Blas Spain 6 875 0.8× 290 0.8× 177 0.9× 128 0.9× 112 0.9× 9 934
Antonio Ojea Spain 10 951 0.9× 368 1.0× 183 0.9× 132 1.0× 139 1.1× 14 1.0k
Pedro Muntañola Spain 6 832 0.8× 258 0.7× 177 0.9× 129 0.9× 100 0.8× 8 874
Wolfgang Hoeltl Austria 11 1.1k 1.0× 370 1.0× 168 0.8× 174 1.3× 287 2.3× 20 1.2k
J. SALVADOR-BAYARRI Spain 10 916 0.9× 308 0.9× 166 0.8× 141 1.0× 121 1.0× 16 997
Ander Astobieta Spain 7 949 0.9× 329 0.9× 183 0.9× 131 0.9× 279 2.3× 14 1.2k
Manuel Sierra Montesinos Spain 6 794 0.8× 251 0.7× 169 0.8× 113 0.8× 97 0.8× 13 839
Jesús Rodríguez-Molina Spain 7 797 0.8× 251 0.7× 210 1.0× 123 0.9× 123 1.0× 7 873

Countries citing papers authored by C Pertusa

Since Specialization
Citations

This map shows the geographic impact of C Pertusa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Pertusa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Pertusa more than expected).

Fields of papers citing papers by C Pertusa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Pertusa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Pertusa. The network helps show where C Pertusa may publish in the future.

Co-authorship network of co-authors of C Pertusa

This figure shows the co-authorship network connecting the top 25 collaborators of C Pertusa. A scholar is included among the top collaborators of C Pertusa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Pertusa. C Pertusa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Rodríguez, Pablo Serrano, et al.. (2011). Utilization of Advanced-Age Donors in Renal Transplantation. Transplantation Proceedings. 43(9). 3340–3343. 4 indexed citations
2.
3.
Gómez, J.M. Fernández, Rosário Madero, E. Solsona, et al.. (2011). The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: external validation of the EORTC risk tables. International braz j urol. 37(5). 671–672. 8 indexed citations
4.
Gómez, J.M. Fernández, Rosário Madero, Eduardo Solsona, et al.. (2009). Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model. The Journal of Urology. 182(5). 2195–2203. 443 indexed citations
5.
Gómez, J.M. Fernández, Eduardo Solsona, Miguel Unda, et al.. (2007). Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials. European Urology. 53(5). 992–1002. 194 indexed citations
6.
Martínez-Piñeiro, J A, Luis Martínez‐Piñeiro, Eduardo Solsona, et al.. (2005). HAS A 3-FOLD DECREASED DOSE OF BACILLUS CALMETTE-GUERIN THE SAME EFFICACY AGAINST RECURRENCES AND PROGRESSION OF T1G3 AND TIS BLADDER TUMORS THAN THE STANDARD DOSE? RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL. The Journal of Urology. 174(4 Part 1). 1242–1247. 139 indexed citations
8.
Solsona, E., Rafael Rodríguez, Jesús Rodríguez Molina, et al.. (2003). Comparison of a standard BCG dose (81 MG) versus a three-fold reduced dose (27 MG) in high risk superficial bladder cancer (TIG3, TIS), A cueto prospective randomised study #95012. European Urology Supplements. 2(1). 190–190. 3 indexed citations
10.
11.
Pertusa, C, et al.. (1992). In vitro Lithotripsy with the Alexandrite Laser. European Urology. 22(1). 62–63. 5 indexed citations
12.
Pertusa, C, et al.. (1991). Lithotripsy with the Alexandrite Laser:Our Initial 100 Clinical Cases(1). European Urology. 20(4). 269–271. 14 indexed citations
13.
Pertusa, C, et al.. (1986). [Non-invasive treatment of urinary lithiasis. II. Local chemolysis].. PubMed. 9(6). 465–8. 1 indexed citations
14.
Pertusa, C, et al.. (1978). Urinary Fibrinogen Degradation Products (FDP) in Bladder Cancer. European Urology. 4(5). 348–350. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026